SCHEMBL13815528

SCHEMBL13815528

CC(C)c1cccc(C=NNc2cc(N3CCOCC3)n3nc(-c4ccncc4)cc3n2)c1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIKFYVE Q9Y2I7 4/20 0.80
KDM4E B2RXH2 7/20 0.47
MAPT P10636 6/20 0.47
LMNA P02545 4/20 0.47
APAF1 O14727 1/20 0.47
HPGD P15428 3/20 0.45
ALDH1A1 P00352 3/20 0.43
SENP7 Q9BQF6 1/20 0.43
SENP6 Q9GZR1 1/20 0.43
HSD17B10 Q99714 2/20 0.42
MAPK1 P28482 2/20 0.42
GAA P10253 1/20 0.42
KMT2A Q03164 2/20 0.40
TSHR P16473 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
FES P07332 1/20 0.40
FER P16591 1/20 0.40
TYK2 P29597 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13263847 1.00 PIKFYVE (0.80) PIKFYVEKDM4EMAPTLMNAAPAF1
SCHEMBL13815527 1.00 PIKFYVE (0.80) PIKFYVEKDM4EMAPTLMNAAPAF1
SCHEMBL13571509 0.89 PIKFYVE (1.00) PIKFYVEKDM4EMAPTLMNAHPGD
SCHEMBL13571511 0.89 PIKFYVE (1.00) PIKFYVEKDM4EMAPTLMNAHPGD
SCHEMBL29364101 0.89 PIKFYVE (1.00) PIKFYVEKDM4EMAPTLMNAHPGD
SCHEMBL13815790 0.87 PIKFYVE (0.81) PIKFYVEKDM4EMAPTLMNAHPGD
SCHEMBL13263545 0.87 PIKFYVE (0.81) PIKFYVEKDM4EMAPTLMNAHPGD
SCHEMBL13263742 0.87 PIKFYVE (0.81) PIKFYVEKDM4EMAPTLMNAHPGD
SCHEMBL20511365 0.87 PIKFYVE (0.61) PIKFYVEKDM4EMAPTLMNAAPAF1
SCHEMBL20511360 0.87 PIKFYVE (0.61) PIKFYVEKDM4EMAPTLMNAAPAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8314098-B2 Pyrazolo-pyrimidine compounds AJINOMOTO CO., INC. (JP) 2012-11-20 US disclosed
US-20110294781-A1 PYRAZOLO-PYRIMIDINE COMPOUNDS AJINOMOTO CO., INC. (JP) 2011-12-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110294781-A1 PYRAZOLO-PYRIMIDINE COMPOUNDS IL23R, IL2, IL17A PIKFYVE 748/4885KDM4E 4325/4885MAPT 2414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.